iris diagnostics private limited
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 18 June 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 11 bids — BIOTEKNIKA ENTERPRISES appeared in 6 of them.
IRIS DIAGNOSTICS PRIVATE LIMITED
IRIS DIAGNOSTICS PRIVATE LIMITED
Financial Details
Registered Office
L-90/164 3rd MahipalpurNA-New Delhi-Delhi-110037-India
Industry Classification
Trading
Company Type
Market Information
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
74
Contract Value
₹4.44 Cr
L1 Bids
17
Recent Win Rate
11.1%
Performance Analytics
IRIS Diagnostics Private Limited Business Analysis: Maximizing Government Tender Success
This comprehensive business analysis report provides a detailed overview of IRIS Diagnostics Private Limited's performance in the government tender landscape. With a focus on financial performance, competitive analysis, and strategic recommendations, this report aims to provide actionable insights for sustainable growth and enhanced market positioning. IRIS Diagnostics demonstrates notable engagement in India's public procurement sector with a 23% win rate.
Executive Summary
IRIS Diagnostics Private Limited has actively participated in 74 government tenders, securing 17 L1 positions, showcasing a 23.0% win rate. The company has successfully converted bids into contracts, achieving a ₹4,43,82,365.0 in government contract value. Despite a strong qualification rate of 63.5%, recent financial performance indicates a need for strategic adjustments to enhance competitiveness and profitability. This report delves into the strengths, weaknesses, opportunities, and threats (SWOT) impacting IRIS Diagnostics's performance, providing targeted recommendations for future growth.
Financial Performance of IRIS Diagnostics
Yearly Performance Overview
IRIS Diagnostics's financial performance in government tenders has shown variability over the years. Key highlights include:
- FY 2018-19: The company secured 3 wins out of 21 bids, with a win rate of 14.29%, resulting in a total contract value of ₹58,82,818.0.